Success Stories: A Drug Development Director from China in the field of Membrane Biology achieves EB1A Case Approval with the Help of Our Hardwork and Assistance!

Posted by wegreened on April 9, 2025 in EB1 Green Card, Biology (Pathology and Immunology, Human Genetics, Genomics, Molecular Biology, Animal, Plant, Microbiology, Genetics, Botany)

Client’s Testimonial:

“My attorney is very helpful, quick-response and has done a great job during the preparation of my EB2 NIW and EB1A cases. I feel very lucky to choose WeGreened for my green card application and will recommend you to my friends once they need.”

On February 21^st, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Drug Development Director in the Field of Membrane Biology (Approval Notice).

General Field: Membrane Biology

Position at the Time of Case Filing: Drug Development Director

Country of Origin: China

Country of Residence at the Time of Filing: China

Approval Notice Date: February 21^st, 2025

Processing Time: 12 months, 26 days

Case Summary:

A Drug Development director contacted our law firm to help him establish his significant contributions to the U.S. by filing for an EB-1A (Alien of Extraordinary Ability) petition. We presented his exceptional professional background and unparalleled experience, which are important to his current and future work at the USCIS.

Upon reviewing his credentials, we found that our client has a Ph.D. in biology and has accomplished a great publication record in his field. His research resulted in:

10 peer-reviewed journal articles (3 first- or co-first-authored), 2 conference abstracts (first-authored), and 1 preprint (first-authored), and these papers have been published in some of the most discerning, high-impact journals in his field of membrane biology.
He has conducted at least 17 reviews for journals to date, and his work has been cited by other scholars in numerous published articles as well.
According to Google Scholar, his work has been cited 808 times in at least 51 countries.
His work has received funding from the National Natural Science Foundation of China (NSFC), the Howard Hughes Medical Institute (HHMI), and the National Institutes of Health (NIH). These fundings support projects that progress science and technology.
His case was further supported by two recommendation letters that he obtained from his fellow experts in the field.

Furthermore, his membrane remodeling and lipid-based drug delivery systems research addresses some of our nation’s and the world’s most pressing issues, including the improvement of therapeutics and drug deliveries of incurable diseases. His strong background in in vitro reconstitution techniques has allowed his research to be particularly original, resulting in his success in fundamentally transforming membrane remodeling and lipid-based drug delivery systems research. He is particularly well-known for his contributions to membrane fusion delineation in basic cellular functions and processes.

Our team’s efforts successfully paid off in conveying to the USCIS that our client is an extraordinary researcher who seeks to enter the United States to continue working in his field of expertise. His extraordinary ability has been demonstrated by sustained international acclaim, and his achievements in the field have been recognized through implementation by others and extensive citation of his work.

We would like to congratulate him on securing EB1A approval even after waiting for a long time. He even filed his I-140 NIW approval with us. We wish him to receive his green card as soon as possible.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%